Ranked #9 of 265 · scores higher than 97% of peers · safety percentile 98
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)
35 peers with a safety percentile of 90–100, including DRUG · Click a bar to see the companies
Why “Lower relative risk”?
The measures below combine into a safety percentile of 98 among Healthcare companies. It is relative: 67 or more is lower relative risk, 33–66 moderate, below 33 higher.
Mainly thanks to its current ratio, debt / equity and beta, which are stronger than most Healthcare peers.
▲a share price that has swung less with the market: stronger than 77% of peers. Beta: 0.20 vs peer median 0.63
▲more short-term assets to cover bills due within a year: stronger than 100% of peers. Current ratio: 36.10× vs peer median 2.59×
▲less borrowing relative to shareholders' equity: stronger than 100% of peers. Debt / equity: <0.01× vs peer median 0.22×
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
Metric by metric
Position: dot = DRUG, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
